Immunology

Last names beginning with: A-G, H-Z

Director,

Flow Cytometry Core

Virus/Host interaction; viral domination of protein synthesis; antiviral compounds, systems biology of viral hemorrhagic fever, novel approaches to virus detection.

Ronald B. Corley, Ph.D.

Chairman

Immune responses; the innate-adaptive interface

Rachel Fearns, Ph.D.

Control of respiratory syncytial virus RNA synthesis

Feng Feng, Ph.D.

Computational immunology; innate immunity; toll-like receptors and their transcriptional network

Lisa Ganley-Leal, Ph.D.

Correlates of immunity in human schistosomiasis; inflammatory bowel disease; B cell in human disease

Caroline A. Genco, Ph.D.

Microbial pathogenesis, vaccine development, host-parasite interactions, and bacterial gene regulation

Suryaram Gummuluru, Ph.D.

HIV immune evasion mechanisms

Andrew J. Henderson, Ph.D.

Cellular signals that regulate HIV transcription and replication

Robin Ingalls, M.D.

Reproductive immunology and the pathogenesis of gonococcal and chlamydia infections

Thomas B. Kepler, Ph.D.

Quantitative systems immunology; vaccine development

Joseph P. Mizgerd, Sc.D.

Acute lower respiratory tract infection; cytokines; innate immunity; neutrophil recruitment and activation; pneumonia; transcriptional and post-transcriptional regulation of gene expression

Gustavo Mostoslavsky, M.D., Ph.D.

Stem cell biology and gene therapy

Elke Mühlberger, Ph.D.

Host response to filovirus infection; molecular mechanisms of filovirus replication and transcription

John R. Murphy, Ph.D.

Structure of the diphtheria toxin repressor; diphtheria toxin calalytic domain and entry into the eukaryotic cell cytosol; structure-function of IL7

Barbara S. Nikolajczyk, Ph.D.

Inflammation in type 2 diabetes and other inflammatory diseases; molecular mechanisms of disease pathogenesis; regulation of IL-1 β production

Ian R. Rifkin, M.D., Ph.D.

Mechanisms responsible for the pathogenesis of systemic lupus erythematosus and lupus-associated atherosclerosis

David E. Seldin, M.D., Ph.D.

Application of transgenic and knockout mouse models to study dysregulated kinases that play a role in the molecular basis of lymphoproliferative diseases and other malignancies